TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15942734

Group type: EXPERIMENTAL
Intervention: Prep (low intensity electrical shock)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Start (loud auditory stimulus)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: PrepStart (combination of Prep and Start)
Number of subjects: 12

Group type: COMPARATOR
Intervention: React (imperative signal for execution of the reaction)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: PrepReact (Prep followed by React)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: StartReact (Start followed by React)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: PrepStartReact (Prep followed by StartReact)
Number of subjects: 12
Study: 12000246

Group type: EXPERIMENTAL
Intervention: Vita-Stat 90550 automated device
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Omron HEM-705CP automated device
Number of subjects: 108

Group type: COMPARATOR
Intervention: Sphygmomanometer
Number of subjects: 108
Study: 10730908

Group type: EXPERIMENTAL
Intervention: Terbinafine 250 mg/day for 12 weeks (T12)
Number of subjects: 496

Group type: EXPERIMENTAL
Intervention: Terbinafine 250 mg/day for 16 weeks (T16)
Number of subjects: 496

Group type: COMPARATOR
Intervention: Itraconazole 400 mg/day for 1 week in every 4 weeks for 12 weeks (I3)
Number of subjects: 496

Group type: COMPARATOR
Intervention: Itraconazole 400 mg/day for 1 week in every 4 weeks for 16 weeks (I4)
Number of subjects: 496
Study: 8815279

Group type: EXPERIMENTAL
Intervention: Aevit and glutaminic acid
Number of subjects: 54

Group type: COMPARATOR
Intervention: Conventional therapy plus glucocorticoids
Number of subjects: 54
Study: 1737529

Group type: EXPERIMENTAL
Intervention: Human insulin (6 separate monthly injections)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Control group (6 insulin-dependent diabetic subjects treated with human insulin)
Number of subjects: 7
Study: 6385785

Group type: EXPERIMENTAL
Intervention: 100 mg dexamethasone
Number of subjects: 86

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 86
Study: 31877840

Group type: EXPERIMENTAL
Intervention: SHAPES intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 30137325

Group type: EXPERIMENTAL
Intervention: Ovarian stimulation with FSH (75 IU)
Number of subjects: 738

Group type: COMPARATOR
Intervention: Ovarian stimulation with Clomiphene Citrate (100 mg)
Number of subjects: 738
Study: 27974124

Group type: EXPERIMENTAL
Intervention: Low-dose gamma globulin (0.2 g/(kg · d)) combined with methylprednisolone
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: High-dose gamma globulin (0.4 g/(kg · d)) combined with methylprednisolone
Number of subjects: 100
Study: 25232263

Group type: EXPERIMENTAL
Intervention: Otilonium bromide 80 mg
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Otilonium bromide 40 mg
Number of subjects: 93

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 93
Study: 23983322

Group type: EXPERIMENTAL
Intervention: Phytotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Phytotherapy only
Number of subjects: 0
Study: 21133786

Group type: EXPERIMENTAL
Intervention: Peer-delivered intervention to encourage hypertension self-management
Number of subjects: 0
Study: 17418644

Group type: EXPERIMENTAL
Intervention: Oxcarbazepine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Other AEDs (Carbamazepine, Phenobarbital, Phenytoin, Valproate)
Number of subjects: 0
Study: 15674409

Group type: EXPERIMENTAL
Intervention: Pressure Support Ventilation with Volume Guarantee (PSV-VG)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Synchronized Intermittent Mandatory Ventilation (SIMV)
Number of subjects: 34
Study: 12503502

Group type: EXPERIMENTAL
Intervention: Stiripentol associated with valproate and clobazam
Number of subjects: 46
Study: 10191742

Group type: EXPERIMENTAL
Intervention: Diathermy knife
Number of subjects: 67

Group type: COMPARATOR
Intervention: Scalpel
Number of subjects: 67
Study: 7779130

Group type: EXPERIMENTAL
Intervention: Tiludronate for 3 months
Number of subjects: 234

Group type: EXPERIMENTAL
Intervention: Tiludronate for 6 months
Number of subjects: 234

Group type: COMPARATOR
Intervention: Etidronate for 6 months
Number of subjects: 234
Study: 2108990

Group type: EXPERIMENTAL
Intervention: HCG supplementation
Number of subjects: 387

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 387
Study: 7284220

Group type: EXPERIMENTAL
Intervention: Group A (6-8ml of 0.5% bupivacaine solution)
Number of subjects: 517

Group type: EXPERIMENTAL
Intervention: Group B (10-14ml of 0.25% bupivacaine solution)
Number of subjects: 517

Group type: EXPERIMENTAL
Intervention: Group C (6-8ml of 0.25% bupivacaine solution)
Number of subjects: 517

Group type: EXPERIMENTAL
Intervention: Group A
Number of subjects: 517

Group type: EXPERIMENTAL
Intervention: Group C
Number of subjects: 517

Group type: COMPARATOR
Intervention: Group A, B, C
Number of subjects: 517

Group type: COMPARATOR
Intervention: Group B, C
Number of subjects: 517
Study: 29949455

Group type: EXPERIMENTAL
Intervention: MABT + treatment as usual (TAU)
Number of subjects: 217

Group type: COMPARATOR
Intervention: Women's health education (WHE) + TAU (active control condition)
Number of subjects: 217

Group type: COMPARATOR
Intervention: TAU only
Number of subjects: 217
Study: 28590363

Group type: EXPERIMENTAL
Intervention: dl‐MPH (40 mg) with ethanol (0.6 g/kg)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: d‐MPH (20 mg) with ethanol (0.6 g/kg)
Number of subjects: 14

Group type: COMPARATOR
Intervention: dl‐MPH (40 mg)
Number of subjects: 14

Group type: COMPARATOR
Intervention: d‐MPH (20 mg)
Number of subjects: 14
Study: 24809922

Group type: EXPERIMENTAL
Intervention: Dual antiplatelet therapy (DAPT) - aspirin and clopidogrel 75 mg/qd or ticlopidine 500 mg/bid
Number of subjects: 120

Group type: COMPARATOR
Intervention: Single antiplatelet therapy (ASA) - aspirin only
Number of subjects: 120
Study: 22761759

Group type: EXPERIMENTAL
Intervention: 2 single doses (3.75 µg hemagglutinin)
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: 2 double doses (7.5 µg hemagglutinin)
Number of subjects: 256

Group type: COMPARATOR
Intervention: 1 dose (control group)
Number of subjects: 256
Study: 20638380

Group type: EXPERIMENTAL
Intervention: Intranasal cocaine (15 mg)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Intranasal cocaine (30 mg)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Intranasal cocaine (45 mg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo (4 mg)
Number of subjects: 8
Study: 17621177

Group type: EXPERIMENTAL
Intervention: Diclofenac sodium ophthalmic solution 0.1%
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study: 15176694

Group type: EXPERIMENTAL
Intervention: FRCUS (Functional Residual Capacity measured by ultrasonic flow meter)
Number of subjects: 23

Group type: COMPARATOR
Intervention: FRCMS (Functional Residual Capacity measured by mass spectrometer)
Number of subjects: 23
Study: 12120937

Group type: EXPERIMENTAL
Intervention: Premature-delayed vaccination (first dose when weight of 2,000 g reached)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Premature vaccination (first dose within 24 h of birth)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Full-term vaccination (first dose within 24 h of birth)
Number of subjects: 136
Study: 9824003

Group type: EXPERIMENTAL
Intervention: Captopril (CAP)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Placebo (PLC)
Number of subjects: 135
Study: 7814825

Group type: EXPERIMENTAL
Intervention: Fluoxetine 60 mg/day
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 2590584

Group type: EXPERIMENTAL
Intervention: Air polishing device
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional rubber cup and paste method (Control)
Number of subjects: 0
Study: 65040

Group type: EXPERIMENTAL
Intervention: Bleomycin
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Radiotherapy
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Combination of Bleomycin and Radiotherapy
Number of subjects: 51
Study: 31206768

Group type: EXPERIMENTAL
Intervention: Dual plasma molecular adsorption system (DPMAS) in addition to plasma exchange
Number of subjects: 162

Group type: COMPARATOR
Intervention: Plasma exchange (control group)
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Both groups (DPMAS and control)
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: DPMAS group
Number of subjects: 162
Study: 28838644

Group type: EXPERIMENTAL
Intervention: Laparoscopic ileocaecal resection
Number of subjects: 143

Group type: COMPARATOR
Intervention: Infliximab
Number of subjects: 143
Study: 25345427

Group type: EXPERIMENTAL
Intervention: Canagliflozin 200 mg/day with OC (levonorgestrel 150 μg + ethinyl estradiol 30 μg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Canagliflozin 300 mg/day with warfarin 30 mg/day
Number of subjects: 0
Study: 23929980

Group type: EXPERIMENTAL
Intervention: Positive social influence
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Negative social influence
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Positive herding
Number of subjects: 0
Study: 21799044

Group type: EXPERIMENTAL
Intervention: T2 quantitation
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: ADC quantitation
Number of subjects: 65
Study: 19402191

Group type: EXPERIMENTAL
Intervention: Ultrasonic dissection
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Waterjet dissection
Number of subjects: 96

Group type: COMPARATOR
Intervention: Dissecting sealer
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: All devices
Number of subjects: 96
Study: 16395539

Group type: EXPERIMENTAL
Intervention: Laparoscopic cholecystectomy combined with intraoperative endoscopic sphincterotomy (LC-IOEST)
Number of subjects: 234

Group type: COMPARATOR
Intervention: Laparoscopic exploration of the common bile duct (LCBDE)
Number of subjects: 234
Study: 15372414

Group type: EXPERIMENTAL
Intervention: 4,000 U subcutaneous epoetin alfa
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: 10,000 U subcutaneous epoetin alfa
Number of subjects: 153
Study: 11335749

Group type: EXPERIMENTAL
Intervention: Thyroxine (T(4)) supplementation
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study: 9274470

Group type: EXPERIMENTAL
Intervention: Antibiotics (300 mg metronidazole, 500 mg amoxycillin, 250 mg clarithromycin, each given four times daily for two weeks)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Antibiotics with H pylori clearance
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Antibiotics with H pylori eradication
Number of subjects: 100

Group type: COMPARATOR
Intervention: Failure of H pylori clearance
Number of subjects: 100

Group type: COMPARATOR
Intervention: Failure of H pylori eradication
Number of subjects: 100
Study: 8519239

Group type: EXPERIMENTAL
Intervention: Metal stents
Number of subjects: 62

Group type: COMPARATOR
Intervention: Polyethylene stents
Number of subjects: 62
Study: 3319453

Group type: EXPERIMENTAL
Intervention: Lactitol
Number of subjects: 18

Group type: COMPARATOR
Intervention: Lactose
Number of subjects: 18
Study: 29099236

Group type: EXPERIMENTAL
Intervention: Biting exercises (soft plastic roll for 5 min/d)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control (no biting exercises)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Biting exercises
Number of subjects: 36
Study: 27411766

Group type: EXPERIMENTAL
Intervention: BodyThink program (smartphone apps)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control group (smartphone apps and small group counseling)
Number of subjects: 68
Study: 25528166

Group type: EXPERIMENTAL
Intervention: Early Supported Discharge (ESD) 1
Number of subjects: 306

Group type: EXPERIMENTAL
Intervention: Early Supported Discharge (ESD) 2
Number of subjects: 306

Group type: EXPERIMENTAL
Intervention: Pooled ESD groups
Number of subjects: 306

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 306
Study: 22787176

Group type: EXPERIMENTAL
Intervention: Intensive multifactorial treatment
Number of subjects: 456

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 456
Study: 21115933

Group type: EXPERIMENTAL
Intervention: finasteride 5 mg/day
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: dutasteride 4 mg/day
Number of subjects: 60

Group type: COMPARATOR
Intervention: no therapy (control)
Number of subjects: 60
Study: 19049350

Group type: EXPERIMENTAL
Intervention: Active Mothers Postpartum (AMP) intervention including ten physical activity group sessions, eight healthy eating classes, and six telephone counseling sessions over a 9‐month period, along with motivational tools such as a workbook, pedometer, and sport stroller.
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Active Mothers Postpartum (AMP) intervention
Number of subjects: 450
Study: 16719617

Group type: EXPERIMENTAL
Intervention: Safe-sex with reminder intervention (bracelet)
Number of subjects: 196

Group type: COMPARATOR
Intervention: Standard safe-sex intervention
Number of subjects: 196

Group type: COMPARATOR
Intervention: Control (drinking and driving) intervention
Number of subjects: 196
Study: 15053710

Group type: EXPERIMENTAL
Intervention: Moral exemplarity attributes (just, brave, caring) identified through free-listing procedure in Study 1.
Number of subjects: 1206

Group type: EXPERIMENTAL
Intervention: Personality profiles for moral exemplars generated through prototypicality- and personality-rating procedures in Study 2.
Number of subjects: 1206

Group type: EXPERIMENTAL
Intervention: Similarity-sorting procedure used to identify typologies of moral exemplarity in Study 3.
Number of subjects: 1206
Study: 11165356

Group type: EXPERIMENTAL
Intervention: 0.3 Hz filter setting with peak-to-peak measurement of P300
Number of subjects: 26

Group type: COMPARATOR
Intervention: 0.01 Hz filter setting with base-peak measurement of P300
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Peak-peak measurement of P300
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Pre-stimulus EEG baseline variability
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: NEG seen only in 0.3 Hz channels
Number of subjects: 26
Study: 9298796

Group type: EXPERIMENTAL
Intervention: Rapid growers
Number of subjects: 142

Group type: COMPARATOR
Intervention: Slow growers
Number of subjects: 142
Study: 8436729

Group type: EXPERIMENTAL
Intervention: Mixed-gender date-rape workshop
Number of subjects: 331

Group type: COMPARATOR
Intervention: Control group (not exposed to workshop)
Number of subjects: 331
Study: 2872803

Group type: EXPERIMENTAL
Intervention: Terazosin (1 to 40 mg daily, administered alone or in combination with other antihypertensive agents)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Terazosin (1 to 40 mg daily)
Number of subjects: 0
Study: 31296043

Group type: EXPERIMENTAL
Intervention: SWCM+MISTT Website (group-3)
Number of subjects: 265

Group type: COMPARATOR
Intervention: Usual Care (group-1)
Number of subjects: 265

Group type: COMPARATOR
Intervention: SWCM (group-2)
Number of subjects: 265
Study: 30055583

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 502
Study: 26704693

Group type: EXPERIMENTAL
Intervention: Ledipasvir/Sofosbuvir (LDV/SOF)
Number of subjects: 264

Group type: EXPERIMENTAL
Intervention: Ledipasvir/Sofosbuvir (LDV/SOF) with Ribavirin (RBV)
Number of subjects: 264

Group type: EXPERIMENTAL
Intervention: Ledipasvir/Sofosbuvir (LDV/SOF) without Ribavirin (RBV)
Number of subjects: 264
Study: 24553033

Group type: EXPERIMENTAL
Intervention: Group BFM: 0.0625% bupivacaine + 2 μg/ml fentanyl + 2 mg morphine in 15 mL saline
Number of subjects: 120

Group type: COMPARATOR
Intervention: Group BF: 0.1% bupivacaine + 2 μg/mL fentanyl in 15 mL saline
Number of subjects: 120
Study: 21508267

Group type: EXPERIMENTAL
Intervention: Full-time wear for 3 months and thereafter at night (group A)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Full-time wear for 1 week and thereafter at night only (group B)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Both groups (A and B)
Number of subjects: 69
Study: 20498395

Group type: EXPERIMENTAL
Intervention: Carboplatin (AUC 5) plus Pegylated liposomal Doxorubicin (30 mg/m²) every 4 weeks
Number of subjects: 976

Group type: COMPARATOR
Intervention: Carboplatin (AUC 5) plus Paclitaxel (175 mg/m²) every 3 weeks
Number of subjects: 976
Study: 17645386

Group type: EXPERIMENTAL
Intervention: Music therapy
Number of subjects: 9
Study: 15099916

Group type: EXPERIMENTAL
Intervention: Cyclazocine (0.4 mg)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Cyclazocine (0.8 mg)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Hydromorphone (5 mg)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Hydromorphone (15 mg)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Cyclazocine (0.2 mg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 12185409

Group type: EXPERIMENTAL
Intervention: Citalopram (10 mg IV)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 12
Study: 9824875

Group type: EXPERIMENTAL
Intervention: Clozapine treatment
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Clozapine titration (6-8 weeks)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Typical antipsychotic drugs (APD)
Number of subjects: 41
Study: 7663868

Group type: EXPERIMENTAL
Intervention: Intra-articular morphine sulfate 1 mg in normal saline 10 ml
Number of subjects: 40

Group type: COMPARATOR
Intervention: Intra-articular 0.5% bupivacaine 10 ml
Number of subjects: 40
Study: 2680154

Group type: EXPERIMENTAL
Intervention: PQ 750 mg with NQ 25 mg
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: PYR 600 mg with NQ 25 mg
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: PYR 800 mg with NQ 40 mg
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: PYR 800 mg with NQ 80 mg
Number of subjects: 118

Group type: COMPARATOR
Intervention: PYR 1,200 mg alone
Number of subjects: 118
Study: 814106

Group type: EXPERIMENTAL
Intervention: Fluspirilene
Number of subjects: 332

Group type: EXPERIMENTAL
Intervention: Penfluridol
Number of subjects: 332

Group type: COMPARATOR
Intervention: Fluphenazine-decanoate
Number of subjects: 332

Group type: COMPARATOR
Intervention: Flupenthixol-decanoate
Number of subjects: 332
Study: 31180194

Group type: EXPERIMENTAL
Intervention: Teplizumab
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study: 27974345

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 8410

Group type: COMPARATOR
Intervention: Other biomarkers
Number of subjects: 8410
Study: 25566874

Group type: EXPERIMENTAL
Intervention: Self-management intervention (self-monitoring for the first week of each month and individualized treatment self-titration schedule)
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: Self-management intervention
Number of subjects: 263
Study: 24165817

Group type: EXPERIMENTAL
Intervention: Target-controlled infusion (TCI) of propofol with alfentanil
Number of subjects: 220

Group type: COMPARATOR
Intervention: Manually controlled infusion (MCI) of propofol with alfentanil
Number of subjects: 220
Study: 22159679

Group type: EXPERIMENTAL
Intervention: Tailored newsletter
Number of subjects: 329

Group type: COMPARATOR
Intervention: Targeted newsletter
Number of subjects: 329

Group type: EXPERIMENTAL
Intervention: Reading the newsletter
Number of subjects: 329

Group type: EXPERIMENTAL
Intervention: Planning to make an appointment for a DFE
Number of subjects: 329
Study: 19364980

Group type: EXPERIMENTAL
Intervention: Doxycycline (50, 100, or 300 mg/d for 2 weeks)
Number of subjects: 60
Study: 16464988

Group type: COMPARATOR
Intervention: Etanercept (ETN) monotherapy
Number of subjects: 315

Group type: EXPERIMENTAL
Intervention: Etanercept (ETN) plus methotrexate (MTX)
Number of subjects: 315
Study: 14998986

Group type: COMPARATOR
Intervention: Linezolid 600 mg every 12 h
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Quinupristin-dalfopristin 7.5 mg/kg every 8 h
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Quinupristin-dalfopristin
Number of subjects: 40

Group type: COMPARATOR
Intervention: Linezolid
Number of subjects: 40
Study: 11392625

Group type: EXPERIMENTAL
Intervention: Tolterodine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oxybutynin
Number of subjects: 0
Study: 9455715

Group type: EXPERIMENTAL
Intervention: Carbopol matrix tablet with normal diet
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Carbopol matrix tablet with high fat diet
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Carbopol matrix tablet with high fat/high protein diet
Number of subjects: 12

Group type: COMPARATOR
Intervention: Lipid matrix tablet with fasting condition
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Lipid matrix tablet with normal diet
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Lipid matrix tablet with high fat diet
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Lipid matrix tablet with high fat/high protein diet
Number of subjects: 12
Study: 8189563

Group type: COMPARATOR
Intervention: Prostaglandin E1 (0, 2.5, 5.0, 7.5, and 10 micrograms)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Prostaglandin E1
Number of subjects: 15
Study: 3074922

Group type: EXPERIMENTAL
Intervention: White spaghetti
Number of subjects: 13

Group type: COMPARATOR
Intervention: Potato
Number of subjects: 13

Group type: COMPARATOR
Intervention: White bread
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Potato with bolognese sauce
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: White spaghetti with bolognese sauce
Number of subjects: 13
Study: 30590573

Group type: EXPERIMENTAL
Intervention: Paracetamol (1000 mg) taken 1 hour prior to pain rating
Number of subjects: 60

Group type: COMPARATOR
Intervention: Chewing gum used 10 minutes prior to pain rating
Number of subjects: 60
Study: 27341326

Group type: EXPERIMENTAL
Intervention: BalanceWear Therapy (BWT), weighted orthotic (WG), worn for 4 hours per day for 5 days
Number of subjects: 33

Group type: COMPARATOR
Intervention: Sham BalanceWear Therapy (SWG), sham-weighted orthotic, worn for 4 hours per day for 5 days
Number of subjects: 33
Study: 25622201

Group type: EXPERIMENTAL
Intervention: sibutramine
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: self-help cognitive-behavioral therapy (shCBT) + sibutramine
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: self-help cognitive-behavioral therapy (shCBT) + placebo
Number of subjects: 104

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 104
Study: 23299158

Group type: EXPERIMENTAL
Intervention: Sufentanil 0.15 ug/kg
Number of subjects: 80

Group type: COMPARATOR
Intervention: Fentanyl 1.5 ug/kg
Number of subjects: 80
Study: 21888011

Group type: EXPERIMENTAL
Intervention: ODK‐0702
Number of subjects: 498